Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of a Transplantable Murine Leukæmia by a Lymphocytopenic Virus

Abstract

IN our laboratory the isolation of a viral agent with lymphocytopenic action in vivo directed our attention to its possible anti-leukæmic action. Anti-tumour properties of this virus are briefly described herein.

This is a preview of subscription content, access via your institution

Access options

Similar content being viewed by others

References

  1. Molomut, N., Padnos, M., and Smith, L. W., J. Nat. Cancer Inst. (in the press).

  2. Smith, L. W., and Patti, J., Fed. Proc., 21, 165 (1963).

    Google Scholar 

  3. Law, L. W., and Dunn, T. B., J. Nat. Cancer Inst., 2, 1037 (1951).

    Google Scholar 

  4. Southam, C. M., Trans. N.Y. Acad. Sci., 22, 657 (1960).

    Article  CAS  Google Scholar 

  5. Love, R., Ann. N.Y. Acad. Sci., 81, 101 (1959).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MOLOMUT, N., PADNOS, M., GROSS, L. et al. Inhibition of a Transplantable Murine Leukæmia by a Lymphocytopenic Virus. Nature 204, 1003–1004 (1964). https://doi.org/10.1038/2041003b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/2041003b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing